Nevro Corporation1800 Bridge Parkwayredwood City Ca 94065 Pma Numberp130022 Supplement Numbers046 Date Received04 15 2022 Decision Date05 13 2022 Product Code Lgw Advisory Committee Neurology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Nevro Corporation1800 Bridge Parkwayredwood City Ca 94065 Pma Numberp130022 Supplement Numbers046 Date Received04 15 2022 Decision Date05 13 2022 Product Code Lgw Advisory Committee Neurology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Nevro Corporation1800 Bridge Parkwayredwood City, CA 94065 PMA NumberP130022 Supplement NumberS046 Date Received04/15/2022 Decision Date05/13/2022 Product Code LGW  Advisory Committee Neurology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
 Nevro Corp Senza™ Spinal Cord Stimulation (SCS) System2022-05-13

Related Finance Registrations
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.